v3.21.2
OPERATING SEGMENTS - Reconciliation (Details)
$ in Millions
 3 Months Ended 6 Months Ended
Jun. 30, 2021
USD ($)
item
Mar. 31, 2021
USD ($)
Jun. 30, 2020
USD ($)
Mar. 31, 2020
USD ($)
Jun. 30, 2021
USD ($)
Jun. 30, 2020
USD ($)
Reconciliation of net income to EBITDA            
Net loss $ (344.0) $ (567.2) $ (561.2)   $ (911.2) $ (2,737.5)
Income tax provision (benefit) (5.2)   (6.1)   (12.0) 62.1
Interest expense 98.9   91.2   261.7 174.0
Depreciation and amortization 105.7   119.7   219.8 242.2
Impairment of long-lived assets, definite and indefinite-lived intangible assets and goodwill           1,851.9
Certain operating expense (income) (4.0)   (1.5)   (1.7) 0.6
Equity in loss of non-consolidated entities 2.7   12.4   5.5 15.3
Cash distributions from non-consolidated entities     6.1   0.3 13.7
Attributable EBITDA 0.7   0.6   (0.1) 0.5
Investment expense (income) (6.3)   (1.3)   (8.3) 8.1
Other expense (0.3)   (1.9)   (5.1) 25.0
Other non-cash rent benefit (11.7)   (3.8)   (19.2) (1.5)
General and administrative - unallocated:            
Merger, acquisition and other costs 4.3   1.8   11.0 2.0
Stock-based compensation expense 8.4   3.7   13.8 6.4
Adjusted EBITDA 150.8   340.3   445.5 337.2
Impairment of goodwill           1,744.3
Impairment of long-lived assets           91.3
Impairment of indefinite-lived intangible assets           8.3
Impairment of definite-lived intangible assets       $ 8.0   8.0
Foreign currency transactions gains (losses) (3.4)   2.1   0.4 0.1
Derivative liability fair value adjustment           0.5
Estimated credit losses (income) contingent lease guarantees 3.7   (3.9)   5.7 (9.2)
Derivative asset fair value adjustment     (6.4)     13.7
Convertible Notes due 2026            
General and administrative - unallocated:            
Derivative liability fair value adjustment           (0.5)
Attributable EBITDA            
Reconciliation of net income to EBITDA            
Income tax provision (benefit) 0.1       (0.1) (0.1)
Interest expense 0.2       0.2  
Depreciation and amortization 2.7   0.7   3.6 1.5
Equity in loss of non-consolidated entities 2.7   12.4   5.5 15.3
Equity in loss of non-consolidated entities excluding International theatre joint ventures 0.3   12.2   1.5 14.3
Attributable EBITDA 0.7   0.6   (0.1) 0.5
Investment expense (income)           (0.2)
Other expense 0.1   0.1   0.2 0.3
Other expense (income)            
General and administrative - unallocated:            
Increases in other expenses related to financing fees     2.8   1.0 2.8
Foreign currency transactions gains (losses) 3.4   (2.1)   (0.4) (0.1)
Derivative liability fair value adjustment           (0.5)
Estimated credit losses (income) contingent lease guarantees 9.2   3.9   (5.7)  
Other expense (income) | Convertible Notes due 2026            
General and administrative - unallocated:            
Derivative liability fair value adjustment     0.0     (0.5)
Other expense (income) | Call Option            
General and administrative - unallocated:            
Estimated credit losses (income) contingent lease guarantees (3.7)          
Derivative asset fair value adjustment (13.7)   (6.4)     13.7
Oden trade name            
General and administrative - unallocated:            
Impairment of indefinite-lived intangible assets       5.9    
Nordic trade names            
General and administrative - unallocated:            
Impairment of indefinite-lived intangible assets       2.4    
Domestic theatres            
General and administrative - unallocated:            
Impairment of goodwill 1,124.9     1,124.9    
Impairment of definite-lived intangible assets 8.0          
International theatres            
General and administrative - unallocated:            
Impairment of goodwill 619.4     $ 619.4    
Impairment of long-lived assets $ 9.9          
Tangible asset impairment, number of theatres | item 23          
Tangible asset impairment, number of screens | item 213          
International theatres | Nordic trade names            
Reconciliation of net income to EBITDA            
Impairment of long-lived assets, definite and indefinite-lived intangible assets and goodwill $ 2.4          
U. S. markets            
General and administrative - unallocated:            
Impairment of long-lived assets $ 81.4          
Tangible asset impairment, number of theatres | item 57          
Tangible asset impairment, number of screens | item 658          
International markets | Oden trade name            
General and administrative - unallocated:            
Impairment of long-lived assets $ 5.9          
Operating Segments [Member] | U. S. markets            
General and administrative - unallocated:            
Adjusted EBITDA 118.0   241.6   (318.4) (245.4)
Operating Segments [Member] | International markets            
General and administrative - unallocated:            
Adjusted EBITDA 32.8   98.7   (127.1) (91.8)
Operating Segments [Member] | International markets | Attributable EBITDA            
Reconciliation of net income to EBITDA            
Equity in loss of International theatre joint ventures $ (2.4)   $ (0.2)   $ (4.0) $ (1.0)